Cargando…
Platelet Transfusion – The New Immunology of an Old Therapy
Platelet transfusion has been a vital therapeutic approach in patients with hematologic malignancies for close to half a century. Randomized trials show that prophylactic platelet transfusions mitigate bleeding in patients with acute myeloid leukemia. However, even with prophylactic transfusions, as...
Autores principales: | Stolla, Moritz, Refaai, Majed A., Heal, Joanna M., Spinelli, Sherry L., Garraud, Olivier, Phipps, Richard P., Blumberg, Neil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4313719/ https://www.ncbi.nlm.nih.gov/pubmed/25699046 http://dx.doi.org/10.3389/fimmu.2015.00028 |
Ejemplares similares
-
Breaking the Mold: Transcription Factors in the Anucleate Platelet and Platelet-Derived Microparticles
por: Lannan, Katie L., et al.
Publicado: (2015) -
Platelet transfusions: trigger, dose, benefits, and risks
por: Blumberg, Neil, et al.
Publicado: (2010) -
NF-κB Links TLR2 and PAR1 to Soluble Immunomodulator Factor Secretion in Human Platelets
por: Damien, Pauline, et al.
Publicado: (2017) -
Immunological Features in the Process of Blood Platelet-Induced Alloimmunisation, with a Focus on Platelet Component Transfusion
por: Garraud, Olivier, et al.
Publicado: (2019) -
New Emerging Developments of Platelets in Transfusion Medicine
por: Stolla, Moritz, et al.
Publicado: (2020)